Basic Information
Enurev Breezhaler
Regulatory Information
EMEA/H/C/002691
Authorised
September 28, 2012
10
November 10, 2021
Company Information
Ireland
Novartis Europharm Limited Elm Park Merrion Road Dublin 4
Novartis Europharm Ltd.
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Enurev Breezhaler is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Overview Summary
Enurev Breezhaler is a medicine that is used to relieve the symptoms of chronic obstructive pulmonary disease (COPD) in adults. COPD is a long-term disease in which the airways and air sacs inside the lungs become damaged or blocked, leading to difficulty breathing. Enurev Breezhaler is used for maintenance (regular) treatment. Enurev Breezhaler contains the active substance glycopyrronium bromide.